Acrux Pharmaceuticals Inc (ACXP)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
David P. Luci
Employees:
22 CAMELOT COURT, WHITE PLAINS, NY 10603
914-949-3898

We are a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization (“WHO”), the U.S. Centers for Disease Control and Prevention (“CDC”), and the U.S. Food and Drug Administration (“FDA”). Our principal executive offices are located at 259 Liberty Avenue, Staten Island, NY.

Data derived from most recent annual or quarterly report
Market Cap 37.761 Million Shares Outstanding10.233 Million Avg 30-day Volume 22.384 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.21
Price to Revenue0.0 Debt to Equity0.0 EBITDA-14.01 Million
Price to Book Value3.1399 Operating Margin0.0 Enterprise Value22.481 Million
Current Ratio17.886 EPS Growth0 Quick Ratio17.508
1 Yr BETA 0.4184 52-week High/Low 8.74 / 2.33 Profit Margin0.0
Operating Cash Flow Growth0.0 Altman Z-Score25.2492 Free Cash Flow to Firm 0
Earnings Report2022-08-10
View SEC Filings from ACXP instead.

View recent insider trading info

Funds Holding ACXP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ACXP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SAILER CARL

  • Director
78,078 2021-11-23 3

DELUCCIA ROBERT J

  • Director
  • 10% Owner
1,035,308 2021-11-19 2

LUCI DAVID P PRESIDENT AND CEO

  • Officer
  • Director
  • 10% Owner
1,058,806 2021-11-19 2

HARRISON THOMAS L

  • Director
50,000 2021-07-01 1

SCODARI JOSEPH C

  • Director
50,000 2021-07-01 1

DEAN JACK H

  • Director
50,000 2021-07-01 1

DONOHUE JAMES J.

  • Director
50,000 2021-07-01 1

SHAWAH ROBERT G. CHIEF FINANCIAL OFFICER

  • Officer
270,000 2021-06-29 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ACURX PHARMACEUTICALS INC ACXP 2022-06-27 17:45:03 UTC -3.0291 4.5991 100000
ACURX PHARMACEUTICALS INC ACXP 2022-06-27 17:15:03 UTC -3.0291 4.5991 100000
ACURX PHARMACEUTICALS INC ACXP 2022-06-27 16:45:03 UTC -3.1319 4.7019 100000
ACURX PHARMACEUTICALS INC ACXP 2022-06-27 16:15:03 UTC -3.1319 4.7019 100000
ACURX PHARMACEUTICALS INC ACXP 2022-06-27 15:45:04 UTC -3.1319 4.7019 100000
ACURX PHARMACEUTICALS INC ACXP 2022-06-27 15:15:03 UTC -3.1319 4.7019 100000
ACURX PHARMACEUTICALS INC ACXP 2022-06-27 14:45:04 UTC -3.1319 4.7019 100000
ACURX PHARMACEUTICALS INC ACXP 2022-06-27 14:15:03 UTC -3.1319 4.7019 100000
ACURX PHARMACEUTICALS INC ACXP 2022-06-27 13:45:04 UTC -4.4634 6.0334 100000
ACURX PHARMACEUTICALS INC ACXP 2022-06-27 13:15:04 UTC -4.4634 6.0334 100000
ACURX PHARMACEUTICALS INC ACXP 2022-06-27 12:45:03 UTC -4.4634 6.0334 100000
ACURX PHARMACEUTICALS INC ACXP 2022-06-24 22:15:03 UTC -4.4299 5.9999 100000
ACURX PHARMACEUTICALS INC ACXP 2022-06-24 21:45:03 UTC -4.4299 5.9999 100000
ACURX PHARMACEUTICALS INC ACXP 2022-06-24 21:15:04 UTC -4.4299 5.9999 100000
ACURX PHARMACEUTICALS INC ACXP 2022-06-24 20:45:03 UTC -4.4299 5.9999 100000
ACURX PHARMACEUTICALS INC ACXP 2022-06-24 20:15:03 UTC -4.4299 5.9999 100000
ACURX PHARMACEUTICALS INC ACXP 2022-06-24 19:45:03 UTC -4.4299 5.9999 100000
ACURX PHARMACEUTICALS INC ACXP 2022-06-24 19:15:03 UTC -4.4299 5.9999 100000
ACURX PHARMACEUTICALS INC ACXP 2022-06-24 18:45:03 UTC -4.284 5.854 100000
ACURX PHARMACEUTICALS INC ACXP 2022-06-24 18:15:04 UTC -4.284 5.854 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund ACXP -600.0 shares, $-1968.0 2022-03-31 N-PORT

Elevate your investments